Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Imatinib: the promise of a "magic bullet" for cancer fulfilled.

Journal of the Medical Association of Georgia - 1 Jan 2000

Henderson Charles A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Benzamides
Share to Gastrointestinal Neoplasms
Share to Imatinib Mesylate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Piperazines

Share to Protein-Tyrosine Kinases

Share to Pyrimidines

Source

Identifiers

PMID: 12743899

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Imatinib: the promise of a "magic bullet" for cancer fulfilled.PMID 12743899Read ↗

Will kinase inhibitors have a dark side?Semantic proximity Read ↗

Targeting oncogene dependence and resistance.Semantic proximity Read ↗

mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?Semantic proximity Read ↗

Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML)Semantic proximity Read ↗

Targeted CML therapy: controlling drug resistance, seeking cureSemantic proximity Read ↗

Dasatinib: a new step in molecular target therapySemantic proximity Read ↗

RET-oncogene-targeting drugs draw notice.Semantic proximity Read ↗

A bright future for KRAS inhibitors.Semantic proximity Read ↗

Do fourth-generation EGFR inhibitors showcase the future of kinase inhibitors?Semantic proximity Read ↗

Treating imatinib-resistant leukemia: the next generation targeted therapies.Semantic proximity Read ↗

Therapy of Chronic Myeloid Leukemia: Twilight of the Imatinib Era?Semantic proximity Read ↗

Imatinib mesylate (Gleevec): targeted therapy against cancer with immune properties.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.